J&J Coronavirus Vaccine Tied To Increased Risk Of Guillain-Barré Syndrome, FDA Warns

The New York Times (7/12, LaFraniere, Weiland) reports the Food and Drug Administration “warned on Monday that Johnson & Johnson’s coronavirus vaccine can lead to an increased risk of a rare neurological condition known as Guillain-Barré syndrome.” While...